(19)
(11) EP 1 406 662 A1

(12)

(43) Date of publication:
14.04.2004 Bulletin 2004/16

(21) Application number: 02740940.8

(22) Date of filing: 03.07.2002
(51) International Patent Classification (IPC)7A61K 47/14, A61K 47/44, A61K 47/10, A61K 31/565
(86) International application number:
PCT/GB2002/003092
(87) International publication number:
WO 2003/006064 (23.01.2003 Gazette 2003/04)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.07.2001 GB 0116619
30.08.2001 US 315711 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • CAHILL, Julie, Kay
    Macclesfield, Cheshire SK10 4TG (GB)
  • GELLERT, Paul, Richard
    Macclesfield,Cheshire SK10 4TG (GB)
  • IRVING, Alan, Marshall
    Macclesfield,Cheshire SK10 4TG (GB)

(74) Representative: Giles, Allen Frank 
AstraZeneca AB,Global Intellectual Property
151 85 Sodertalje
151 85 Sodertalje (SE)

   


(54) PHARMACEUTICAL FORMULATION FOR THE INTRAMUSCULAR ADMINISTRATION OF FULVESTRANT